Sudhir Agrawal, D. Phil

2013

In 2013, Sudhir Agrawal, D. Phil earned a total compensation of $2.7M as President of Research at Idera Pharmaceuticals, a 321% increase compared to previous year.

Compensation breakdown

Bonus$274,500
Option Awards$1,875,425
Salary$549,000
Other$31,589
Total$2,730,514

Phil received $1.9M in option awards, accounting for 69% of the total pay in 2013.

Phil also received $274.5K in bonus, $549K in salary and $31.6K in other compensation.

Rankings

In 2013, Sudhir Agrawal, D. Phil's compensation ranked 2,819th out of 12,286 executives tracked by ExecPay. In other words, Phil earned more than 77.1% of executives.

ClassificationRankingPercentile
All
2,819
out of 12,286
77th
Division
Manufacturing
941
out of 4,612
80th
Major group
Chemicals And Allied Products
246
out of 1,462
83rd
Industry group
Drugs
165
out of 1,156
86th
Industry
Biological Products, Except Diagnostic Substances
24
out of 196
88th
Source: SEC filing on April 25, 2016.

Phil's colleagues

We found two more compensation records of executives who worked with Sudhir Agrawal, D. Phil at Idera Pharmaceuticals in 2013.

2013

Louis Arcudi

Idera Pharmaceuticals

Chief Financial Officer

2013

Robert Arbeit

Idera Pharmaceuticals

Former Vice President, Clinical Development

In-depth

You may also like